Hospira Revenue and Competitors

Chicago, IL USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Hospira's estimated annual revenue is currently $1.3B per year.(i)
  • Hospira's estimated revenue per employee is $201,000

Employee Data

  • Hospira has 6486 Employees.(i)
  • Hospira grew their employee count by 3% last year.

Hospira's People

NameTitleEmail/Phone
1
OfficerReveal Email/Phone
2
Director Reimbursement ServicesReveal Email/Phone
3
Chemical Quality DirectorReveal Email/Phone
4
Director TransformationReveal Email/Phone
5
Associate Director, Global Regulatory Affairs, On-Market Generics ProductsReveal Email/Phone
6
Director, Sterile Manufacturing and ValidationReveal Email/Phone
7
Director R&DReveal Email/Phone
8
Sr. Program Manager, Biologics PlatformReveal Email/Phone
9
Area Security ManagerReveal Email/Phone
10
Manager, Regulatory AffairsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$13.1M6530%N/AN/A
#2
$75.6M3767%N/AN/A
#3
$23.9M11913%$35MN/A
#4
$12.7M63-3%N/AN/A
#5
$5.4M27-25%N/AN/A
#6
$6M30-35%N/AN/A
#7
$6.6M33-8%N/AN/A
#8
$13.5M67-3%N/AN/A
#9
$186.3M92719%N/AN/A
#10
$4.4M22-4%N/AN/A
Add Company

What Is Hospira?

Created from the core global hospital products business of Abbott Laboratories, Hospira is a leader in the development, manufacture and marketing of medication delivery systems, specialty injectable pharmaceuticals and critical care devices, as well as custom manufacturing services. Among one of the largest manufacturers of hospital products in the United States, Hospira has sales of approximately $2.5 billion. Headquartered in Lake Forest, Ill., north of Chicago. Hospira has 14 manufacturing plants, five distribution centers and approximately 13,000 employees worldwide. With leading positions in most of its U.S. markets, Hospira offers essential hospital products, broad and unique manufacturing capabilities, and new technology solutions for hospitals to improve medication and safety management. By working with its customers to integrate technologies at the point of care, Hospira is positioned to become the partner of choice for improving patient and workplace safety, clinical outcomes and cost management, and caregiver efficiency and effectiveness.

keywords:N/A

N/A

Total Funding

6486

Number of Employees

$1.3B

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Hospira News

2022-04-20 - Normal Saline Competitive Market Size 2022-2029| Key ...

Baxter; Hospira (Pfizer); Fresenius Kabi; BBraun; Otsuka; Kelun Group; CR Double-Cran; SSY Group; Cisen; Denis Chem Lab Limited...

2022-04-20 - Parenteral Nutrition Market Size, Outlook And Forecast ...

Baxter International, Hospira, B. Braun Melsungen, Grifols International, Fresenius Kabi, Otsuka Pharmaceutical Factory, Actavis,...

2022-04-17 - Eagle Pharmaceuticals Reaches Settlement Agreement with Hospira Related to BENDEKA® (bendamustine hydrochloride) until January 17, 2028

Eagle had asserted two Orange Book-listed patents against Hospira related to its new drug application (“NDA”) referencing BENDEKA®. The...

2012-05-10 - Propofol drug shortages: The economic problem of a generic injectable

Three years ago, propofol was available from three companies. Besides Hospira, Teva Pharmaceutical and APP Pharmaceticals also made the sterile injectable drug. But certain lots of Teva propofol were subject to a 2009 recall due to possible contamination. Hospira also recalled batches of its dru ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2725M7209N/AN/A
#2
N/A215164%N/A
#3
$12600M22184N/AN/A
#4
$17112M25532-1%N/A
#5
$18300M2660310%$800M